Physiologic particularities of muscle impairments in the patient with COPD;Particularidades fisiopatológicas de las alteraciones musculares en el paciente con EPOC

Nutricion Hospitalaria

Volumn 21, Issue SUPPL. 3, 2006, Pages 62-68

  Gea, J ^a   Orozco Levi, M ^b   Barreiro, E ^b  

^a HOSPITAL DEL MAR   (Spain)

^b NONE

Author keywords

Adaptation; COPD; Muscle Dysfunction; Peripheral Muscles; Respiratory Muscles

Indexed keywords

BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; MUSCLE DISEASE; MYOPATHY; NUTRITIONAL DISORDER; OXIDATIVE STRESS; PHYSICAL ACTIVITY; REVIEW;

HUMANS; MUSCLE, SKELETAL; MUSCULAR DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 33745088299     PISSN: 02121611     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Epstein SK: An Overview on Respiratory Muscle Function, Clin Chest Med 1994; 15: 619-639.
2. Hamilton AL, Killian KJ, Summers E, Jones NL: Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 52:2021-2031.
3. Gea J, Orozco-Levi M, Barreiro E, Ferrer A, Broquetas J: Structural and functional changes in the skeletal muscles of COPD patients: The "Compartments" Theory. Mon Arch Chest Dis 2001; 56:214-224.
4. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report. Bethesda, 2004. National Heart, Lung and Blood Institute. Update of the Management Sections, GOLD website, www.goldcopd.com.
5. Coronell C, Orozco-Levi M, Méndez R, Ramírez A, Gáldiz JB, Gea J: Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 2004; 24:129-136.
6. Rochester DF, Braun NMT, Arora NS: Respiratory muscle strength in chronic obstructive pulmonary disease. Am Rev Respir Dis 1979; 119:151-154.
7. Goldman MD, Grassino A, Mead J, Sears A: Mechanics of the human diaphragm during voluntary contraction: Dynamics. J Appl Physiol 1978; 44:840-848.
8. Di Francia M, Barbier D, Mege JL, Orehek J: Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150:1453-1455.
9. Gosker HR, Wouters EF, Van der Vusse GJ, Schols AM: Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000; 71:1033-1047.
10. Barreiro E, De la Puente B, Minguella J, Corominas JM, Serrano S, Hussain S, Gea J: Oxidative stress and respiratory muscle dysfunction in severe COPD. Am J Respir Crit Care Med 2005; 171:1116-1124.
11. Similowsky Th, Yan S, Gaithier AP, Macklem PT: Contractile properties of the human diaphragm during chronic hyperinflation. N Eng J Med 1991; 325:917-923.
12. Levine S, Kaiser L, Leferovich J, Tikunov B: Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997; 337:1799-1806.
13. Gea J, Pastó M, Ennion S, Goldspink G, Broquetas JM: Expression of the genes corresponding to Myosin Heavy Chain isoforms (MyHC I, IIa and IIx) in the diaphragm of patients suffering from COPD. Eur Respir J 1998; 12(Supl. 28):267 s.
14. Orozco-Levi M, Gea J, Lloreta J y cols.: Subcellular adaptation of the human diaphragm in Chronic Obstructive Pulmonary Disease. Eur Respir J 1999; 13:371-378.
15. Gea J, Hamid Q, Czaika G, Zhu E, Mohan-Ram V, Goldspink G, Grassino A: Expression of Myosin Heavy Chain isoforms in the respiratory muscles following inspiratory resistive breathing. Am J Respir Crit Care Med 2000; 161:1274-1278.
16. Zhu E, Petroff B, Gea J, Comtois N, Grassino A: Diaphragm muscle injury after inspiratory resistive breathing. Am J Respir Crit Care Med 1997; 155:1110-1116.
17. Orozco-Levi M, Lloreta J, Minguella J, Serrano S, Broquetas J, Gea J: Injury of the human diaphragm associated with exertion and COPD Am J Respir Crit Care Med 2001; 164:1734-1739.
18. Lloreta J, Orozco-Levi M, Gea J: Broquetas J: Selective diaphragmatic mitochondrial abnormalities in a patient with marked airflow obstruction. Ultrastruct Pathol 1996; 20:67-71.
19. Levine S, Nguyen T, Friscia M, Zhu J, Szeto W, Kucharczuk JC, Tikunov BA, Rubinstein NA, Kaiser LR, Shrager JB: Parasternal intercostal muscle remodeling in severe chronic obstructive pulmonary disease. J Appl Physiol (en prensa).
20. Campbell JA, Hughes RL, Shagal V, Frederiksen J, Shields TW: Alterations in intercostal muscle morphology and biochemistry in patients with chronic obstructive lung disease. Am Rev Respir Dis 1980; 122:679-686.
21. Gea J. Myosin gene expression in the respiratory muscles. Eur Resp J 1997; 10:2404-2410.
22. Orozco-Levi M, Gea J, Sauleda J, Corominas JM, Minguella J, Arán X, Broquetas JM: Structure of the latissimus dorsi muscle and respiratory function. J Apply Physiol 1995; 78:1132-1139.
23. Rochester DF, Braun NMT: Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 132:42-47.
24. Ramírez A, Orozco-Levi M, Barreiro E y cols.: Expiratory muscle endurance in chronic obstructive pulmonary disease. Thorax 2002; 57:132-136.
25. Barreiro E, Ferrer A, Hernández-Frutos N, Palacio J, Broquetas J, Gea J: Expiratory function and cellular properties of the external oblique muscle in patients with extremely severe COPD. Am J Crit Care Med 1999; 159 (suppl): A588.
26. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F: Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:629-634.
27. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM: Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow obstruction. Am Rev Respir Dis 1992; 146:935-940.
28. Schols A, Wousters E, Soeters P, Westertep K: Body composition by bioelectrical impedance analysis compared to deterium dilution and skinfold anthropometry in patients xith chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 53:421-424.
29. Jakobsson P, Jorfeldt L, Brundin A: Skeletal muscle metabolites and fiber types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990; 3:192-196.
30. Jakobsson P, Jordfelt L, Henriksson: Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151:374-377.
31. Simard C, Maltais F, Leblanc P, Simard PM, Jobin J: Mitochondrial and capillarity changes in vastus lateralis muscle of COPD patients: electron microscopy study. Med Sci Sports Exerc 1996; 28:S95.
32. Satta A, Migliori GB, Spanevello A y cols.: Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10:2853-2860.
33. Whittom F, Jobin J, Simard PM, LeBlanc P, Simard C, Bernard S, Belleau R, Maltais F: Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients. Med Sci Sports Exerc 1998; 30:1467-1474.
34. Sala E, Roca J, Marrades RM, Alonso J, González de Suso JM, Moreno A, Barberà JA, Nadal J, De Jover L, Rodríguez-Roisín R, Wagner PD: Effect of endurance training on skeletal muscle bioenergetic in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:1726-1734.
35. Orozco-Levi M, Coronell C, Ramírez-Sarmiento A, Lloreta J, Martínez-Llorens J, Gáldiz JB, Gea J: Injury of peripheral muscles in susceptible smokers with chronic obstructive pulmonary disease (en revisión).
36. Casadevall C, Suelves M, Coronell C, Gea J, Muñoz-Cànoves: Transcriptional changes of genes involved in muscle regeneration in the intercostals muscle of COPD (en revisión).
37. Hernandez N, Orozco-Levi M, Belalcázar V y cols.: Dual morphometrical changes of the deltoid muscle in patients with COPD. Respir Physiol Neurobiol 2003; 134:219-229.
38. Gea J, Pasto M, Carmona M, Orozco-Levi M, Palomeque J, Broquetas J: Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 2001; 17:939-945.
39. Sato Y, Asoh T, Honda Y, Fujimatso Y, Higuchi I, Oizumi K: Morphological and histochemical evaluations of biceps muscle in patients with chronic pulmonary emphysema manifesting generalized emaciation. Eur Neurol 1997; 37:116-121.
40. Casadevall C, Coronell C, Ramírez A, Barreiro E, Orozco-Levi M, Gea J: Local expression of the gene encoding TNF-alpha in the external intercostal and quadriceps muscles of severe COPD patients. Am J Respir Crit Care Med 2003; 167 (suppl):A29.
41. Flores EA, Bristain BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW: Infusion of tumor necrosis factor /cachectin promotes muscle metabolism in the rat. J Clin Invest 1989; 83:1614-1622.
42. Hall-Angeras M, Angeras U, Zamir O, Hasselgren PO, Fischer JE: Interaction between corticosterone and tumor necrosis factor simulated protein breakdown in rat skeletal muscle similar to sepsis. Surgery 1990; 108: 460-466.
43. Jackson MJ, O'Farrel S: Free radicals and muscle damage. Br Med Bull 1993; 49:630-641.
44. Barreiro E, Gea J, Corominas JM, Hussain SN: Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003; 29:771-778.
45. Gea J, Barreiro E, Hussain SNA: Different oxidative stress and nitrosative stress profiles in respiratory and peripheral muscles of COPD patients. Am J Respir Crit Care Med (en prensa).
46. Schols A, Creutzberg E, Buurman W, Campfield L, Saris W, Wouters E: Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1220-1226.
47. Schols A, Buurman W, Van den Brekel S y cols.: Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51:819-824.
48. Diffee GM, Caiozzo VJ, Herrick RE, Baldwin KM: Contractile and biochemical properties of rat soleus and plantaris after hindlimb suspension. Am J Physiol 1991; 260 (Cell Physiol 29):C528-C534.
49. Bloomfield SA: Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 1997; 29:197-206.
50. Maltais F, Leblanc P, Simard C, Jobin J, Berubé C, Bruneau J, Carrier L, Belleau R: Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:442-447.
51. Le Bourdelles G, Viires N, Boczkowski J y cols.: Effects of mechanical ventilation on diaphragmatic contractile properties in rats. Am J Respir Crit Care Med 1994; 149:1539-1544.
52. Deconinck N, Van Parijs V, Bleeckers-Bleukx G y cols.: Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscul Disord 1998; 8:186-192.
53. Polkey MI, Moxham J: Clinical aspects of respiratory muscle dysfunction in the critically ill. Chest 2001; 119:926-939.
54. Barreiro E, Comtois AS, Mohammed S, Lands L, Hussain SNA: Role of heme oxygenases in sepsis-induced diaphragmatic contractile dysfunction and oxidative stress. Am J Physiol Lung Cell Mol Physiol 2002; 283:L476-L484.
55. Spizer AR, Giancarlo T, Mahler L: Nueromuscular causes of prolonged ventilator dependency. Muscle Nerve 1992; 15:682-686.
56. Mehta S, Nelson DL, Klinger JR, Buczko GB, Levy MM: Prediction of post-extubation work of breathing. Crit Care Med 2000; 28:1341-1346.